Improving clinical trial access for non-English speakers
Official title: INcreasing CLinical Trial OpportUnities anD Enrollment of Non-English Speaking Research Subjects: A Revised Research Pathway (INCLUDE)
Funded at Mainehealth · NIH-11046220 · Data updated 2026-11-12
This study is looking at how to make clinical trials more welcoming for people who don't speak English, so everyone can have a fair chance to participate and benefit from new treatments.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mainehealth NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $249,994 |
| NIH project number | 1U01FD008261-01 |
| Project ID | NIH-11046220 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are non-English speaking individuals who may benefit from increased access to clinical trials.
✕Less likely to help
Patients who are proficient in English or those who do not wish to participate in clinical trials may not receive any benefit from this research.
What this research studies
This research aims to address the significant underrepresentation of non-English speaking individuals in clinical trials, which leads to health inequities. It identifies barriers to enrollment, such as mistrust, logistical challenges, and regulatory complexities. By employing a modified Delphi method, the study seeks to gather insights from various stakeholders, including IRB members and community representatives, to develop best practices for overcoming these barriers. The ultimate goal is to create a more inclusive clinical trial environment that facilitates participation from diverse populations.
Why it matters
Potential benefit: If successful, this research could enhance the representation of non-English speakers in clinical trials, leading to more equitable healthcare outcomes.
How similar studies have gone: While many studies have highlighted the barriers faced by non-English speakers in clinical trials, this research aims to propose and test novel solutions, making it a potentially groundbreaking approach.
Where this research is happening
-
Mainehealth
Portland, United States Active
Researchers
- Principal investigator: Chessa, Frank — Mainehealth
- Study coordinator: Chessa, Frank
Related research
Other NIH-funded projects on the same topics.
-
Predicting which kids will grow into obesity using early-life data
Aimed at kids 0-11, this project uses early health data and biology to forecast obesity risk so parents and doctors can act early.
-
Energy metabolism changes in smooth muscle cells and aortic disease progression
Aims to understand how energy use in smooth muscle cells affects the progression of aortic aneurysm and dissection in people with aortic diseases.
-
MaineHealth Cancer Care Network reaches patients where they live
A Maine-based program aims to bring cancer care closer to home by coordinating care across local hospitals and clinics for adults and children with cancer.
-
Improving care for opioid use disorder in the ICU
This project helps hospital staff in intensive care units provide better care for patients with opioid use disorder.
-
PFAS exposure in kids: how early chemicals affect puberty and bone health
This NIH grant studies how common PFAS chemicals in children’s blood might delay puberty and affect bone health, using data from a large pediatric cohort.
-
Ceftaroline-meropenem combo to beat MRSA in cystic fibrosis
A new combination antibiotic approach is being tested to help people with cystic fibrosis who have MRSA infections that resist standard treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.